Work

Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.3116

Authors: Steven Michael Blum, Neal Smith, Moshe Sade-Feldman, Dennie T. Frederick, Russell William Jenkins, Justine Vanessa Cohen, Donald P. Lawrence, Meghan Mooradian, Christine Freedman, Riley Fadden, Krista M. Rubin, Sarah Richey, Keith Flaherty, Jennifer Ann Wargo, Nir Hacohen, Ryan J. Sullivan, Genevieve Marie Boland, Alexandra C Villani

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Harvard University, The University of Texas MD Anderson Cancer Center, Broad Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3029793603

Cites:

Cited by:

Related to: 10